Home538965 • BOM
add
Concord Drugs Ltd
Previous close
₹30.41
Day range
₹29.50 - ₹31.00
Year range
₹26.10 - ₹44.96
Market cap
303.70M INR
Avg Volume
6.59K
P/E ratio
90.29
Dividend yield
-
Primary exchange
BOM
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 103.92M | -33.57% |
Operating expense | 18.21M | -6.87% |
Net income | 389.00K | 111.48% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 10.22M | 196.94% |
Effective tax rate | 32.82% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.25M | 27.78% |
Total assets | 651.42M | 10.77% |
Total liabilities | 310.28M | 24.17% |
Total equity | 341.14M | — |
Shares outstanding | 9.72M | — |
Price to book | 0.87 | — |
Return on assets | — | — |
Return on capital | 3.12% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 389.00K | 111.48% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Website
Employees
185
